The role of growth hormone in improving oocyte quality in IVF cycles
- Author:
Maria Jesusa B. Banal-Silao, MD, FPOGS, FPSRM, FPSGE, FPSUOG
1
Author Information
- Publication Type:Journal Article
- Keywords: oocyte quality; suboptimal responder
- MeSH: growth hormone; hormone receptor; IGF-1; IVF
- From: Philippine Journal of Reproductive Endocrinology and Infertility 2023;20(1):12-23
- CountryPhilippines
- Language:English
-
Abstract:
Background:Growth hormone has been used as an adjunct in ovarian stimulation of IVF cycles for the past three decades. However, the exact mechanism of its role in improving oocyte quality has not been thoroughly investigated. Although a clear indication for GH co-treatment is in infertile women with GH deficiency, GH has been given mostly to poor ovarian responders.
Method:This paper is a review of the most recent published data on the role of GH supplementation in improving oocyte quality in younger women who are suboptimal or unexpected poor responders to standard ovarian stimulation.
Results:Retrospective cohort and randomized trials demonstrated an improvement in oocyte quality through morphological parameters, mitochondrial function, biomarkers, GH receptors, insulin growth factor, markers of oxidative stress, mature oocytes, good quality embryos, implantation rate, clinical pregnancy and live birth.
Conclusion:Current data suggest GH supplementation may improve oocyte and embryo qualities, endometrial receptivity, clinical pregnancy and live birth. However, better quality evidence is needed before a recommendation can be made for GH supplementation to be given to infertile women who are suboptimal or poor ovarian responders. - Full text:Article 4.pdf
